Purpose Corneal collagen crosslinking (CXL) is the primary treatment for progressive
keratoconus which has a significant impact on vision and quality of life. Our study aimed to …

Abstract Background/Aims To identify the domains of quality of life (QoL) in people with
keratoconus. Methods Semi structured in-depth in person and telephone interviews were …

Purpose Corneal crosslinking (CXL) procedures are the treatment of choice in halting
progressive corneal ectasia and preserving visual acuity due to keratoconus. Pulsed …

Objective To define how estimates of keratoconus progression following collagen cross-
linking (CXL) vary according to the parameter selected to measure corneal shape. Materials …

Keratoconus is a progressive corneal disorder characterized by thinning and conical
protrusion, leading to visual impairment that often necessitates advanced treatment …

Purpose Corneal collagen crosslinking (CXL) is the primary treatment for progressive
keratoconus and can be performed with the epithelium on or off. Evidence is needed to …

Purpose: To report outcomes in patients with progressive keratoconus who underwent a
standardized protocol of transepithelial phototherapeutic keratectomy (t-PTK) laser followed …

Background Keratoconus in patients can progress at different ages and rates. This creates
difficulty in determining optimal timing for follow-up interventions such as corneal cross …

Purpose: Corneal collagen crosslinking (CXL) is the primary treatment for progressive
keratoconus and can be performed with the epithelium on or off. Evidence is needed to …

The long-term effectiveness of corneal cross-linking in keratoconus, as well as the mental
health toll of the disease, the emergence of surgical interventions, and persistence with …